本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Arcus Biosciences Inc.

8.47
-0.1200-1.40%
盘后8.470.00000.00%16:20 EDT
成交量:29.72万
成交额:250.91万
市值:8.97亿
市盈率:-2.02
高:8.75
开:8.60
低:8.33
收:8.59
数据加载中...
2024/06/06

重要事件披露

Form 8-K - Current report
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities